Clinical Trial Update: Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of a Single Rectal Application of 10 mg NRL001 in Elderly Subjects [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated safety, tolerability, pharmacodynamics and pharmacokinetics of a single 10 mg rectal dose of NRL001 in elderly subjects with fecal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fecal Incontinence

Drugs mentioned

• NRL001

Snippet

Sponsor: Norgine | Conditions: Fecal Incontinence | Phase 1 | Status: COMPLETED